Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Product Landscape, 2021
October 2021
264
About the Report
About the Report
Therapeutic Drug Monitoring Tests-Medical Devices Pipeline Product Landscape, 2021
Summary
GlobalData's Medical Devices sector report, Therapeutic Drug Monitoring Tests-Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Therapeutic Drug Monitoring Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Therapeutic Drug Monitoring Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Therapeutic Drug Monitoring Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Companies
20/20 GeneSystems Inc Abbott Diagnostics Accelerated Medical Diagnostics LLC Adaptive Biotechnologies Corp Affinergy LLC Animated Dynamics Inc Applied Research using OMIC Sciences SL ARK Diagnostics Inc AutoGenomics Inc Avacta Group Plc BG Medicine Inc BIOHOPE Scientific SL BioMark Diagnostics Inc Boston University Cancer Genetics Inc CCC Diagnostics LLC Centre Hospitalier Universitaire de Nice Chronix Biomedical Inc Cognizance Biomarkers LLC Columbia University Denovo Biolabs Pvt Ltd DNAPrint Genomics Inc (Inactive) Dublin City University ELITechGroup Inc Eurobio Scientific SA Fred Hutchinson Cancer Research Center Gene Express, Inc. (Inactive) GenMark Diagnostics Inc GlucoSentient Inc Horiba Ltd Instrumentation Laboratory Co Johns Hopkins University KIYATEC Inc Medibio Ltd Medical Research Council Metabolon Inc Newcastle University Nipro Europe N.V. Nuclea Biotechnologies Inc. (Inactive) Oncomark Ltd Pax Neuroscience Inc Pelago Bioscience AB Pennsylvania State University Pop Test LLC Prediction Sciences LLC (Inactive) Progenika Biopharma SA PrognosDx Health Inc Proteomika (Inactive) Purdue University Queen Mary University of London Roche Diagnostics Corp Roche Diagnostics International Ltd Rockland Immunochemicals Inc SAGA Diagnostics AB Sagemedic Corp Saladax Biomedical Inc Siemens Healthcare Diagnostics Inc Sirius Genomics Inc Spanish National Research Council SQI Diagnostics Inc T2 Biosystems Inc Thermo Fisher Scientific Inc Universidade Feevale University of Colorado University of Colorado Denver University of North Dakota University of Queensland University of Washington
Table of Contents
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Therapeutic Drug Monitoring Tests Overview
3 Products under Development
3.1 Therapeutic Drug Monitoring Tests-Pipeline Products by Stage of Development
3.2 Therapeutic Drug Monitoring Tests-Pipeline Products by Segment
3.3 Therapeutic Drug Monitoring Tests-Pipeline Products by Territory
3.4 Therapeutic Drug Monitoring Tests-Pipeline Products by Regulatory Path
3.5 Therapeutic Drug Monitoring Tests-Pipeline Products by Estimated Approval Date
3.6 Therapeutic Drug Monitoring Tests-Ongoing Clinical Trials
4 Therapeutic Drug Monitoring Tests-Pipeline Products under Development by Companies
4.1 Therapeutic Drug Monitoring Companies-Pipeline Products by Stage of Development
4.2 Therapeutic Drug Monitoring Tests-Pipeline Products by Stage of Development
5 Therapeutic Drug Monitoring Companies and Product Overview
6 Therapeutic Drug Monitoring- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Figure
List of Figures
Therapeutic Drug Monitoring Tests-Pipeline Products by Stage of Development
Therapeutic Drug Monitoring Tests-Pipeline Products by Segment
Therapeutic Drug Monitoring Tests-Pipeline Products by Territory
Therapeutic Drug Monitoring Tests-Pipeline Products by Regulatory Path
Therapeutic Drug Monitoring Tests-Pipeline Products by Estimated Approval Date
List of Table
List of Tables
Therapeutic Drug Monitoring Tests-Pipeline Products by Stage of Development
Therapeutic Drug Monitoring Tests-Pipeline Products by Segment
Therapeutic Drug Monitoring Tests-Pipeline Products by Territory
Therapeutic Drug Monitoring Tests-Pipeline Products by Regulatory Path
Therapeutic Drug Monitoring Tests-Pipeline Products by Estimated Approval Date
Therapeutic Drug Monitoring Tests-Ongoing Clinical Trials
Therapeutic Drug Monitoring Companies-Pipeline Products by Stage of Development
Therapeutic Drug Monitoring Tests-Pipeline Products by Stage of Development
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.